Legis Daily

END 7-OH Act

USA119th CongressHR-8000| House 
| Updated: 3/19/2026
Gus M. Bilirakis

Gus M. Bilirakis

Republican Representative

Florida

Judiciary Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This legislative proposal, titled the "End Needless Distribution of 7-OH Act" or "END 7-OH Act," aims to modify the Controlled Substances Act. Its primary objective is to designate synthetic 7-hydroxymitragynine as a Schedule I controlled substance, a classification reserved for substances with a high potential for abuse and no currently accepted medical use. The bill specifically adds 7-hydroxymitragynine, including its synthetic equivalents, to Schedule I of the Act. A crucial provision of this amendment is the explicit exclusion of 7-hydroxymitragynine that is naturally contained within the plant Mitragyna speciosa Korth , commonly known as kratom . This distinction means that only the synthetic form of the compound would be subject to the stringent controls of a Schedule I substance, while the naturally occurring form in kratom would not be.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 19, 2026
Introduced in House
Mar 19, 2026
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • March 19, 2026
    Introduced in House


  • March 19, 2026
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

END 7-OH Act

USA119th CongressHR-8000| House 
| Updated: 3/19/2026
This legislative proposal, titled the "End Needless Distribution of 7-OH Act" or "END 7-OH Act," aims to modify the Controlled Substances Act. Its primary objective is to designate synthetic 7-hydroxymitragynine as a Schedule I controlled substance, a classification reserved for substances with a high potential for abuse and no currently accepted medical use. The bill specifically adds 7-hydroxymitragynine, including its synthetic equivalents, to Schedule I of the Act. A crucial provision of this amendment is the explicit exclusion of 7-hydroxymitragynine that is naturally contained within the plant Mitragyna speciosa Korth , commonly known as kratom . This distinction means that only the synthetic form of the compound would be subject to the stringent controls of a Schedule I substance, while the naturally occurring form in kratom would not be.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 19, 2026
Introduced in House
Mar 19, 2026
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • March 19, 2026
    Introduced in House


  • March 19, 2026
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Gus M. Bilirakis

Gus M. Bilirakis

Republican Representative

Florida

Judiciary Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted